Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Pfizer Enters into Agreement with 3SBio for Innovative Cancer Treatment
Friday, July 25, 2025Pfizer has completed a global licensing agreement with SBio excluding China to develop manufacture and commercialise SSGJ a bispecific antibody targeting PD and VEGF
Candel Therapeutics Secures EMA Orphan Designation for Pancreatic Cancer Therapy
Friday, July 25, 2025Candel Therapeutics has received Orphan Designation from the European Medicines Agency EMA for its lead investigational immunotherapy candidate CAN for the treatment of pancreatic cancer
Kling Bio and Sanofi Partner to Accelerate Discovery of Neutralising Antibodies
Friday, July 25, 2025Kling Bio has announced a new collaboration and licence option agreement with SanofiThe partnership will focus on discovering neutralising antibodies and viral epitopes using Kling Bios proprietary B cell technology platform KlingSelect
Matchpoint Therapeutics Enters into Agreement with Novartis to Develop Oral Treatments for Inflammatory Diseases
Friday, July 25, 2025Matchpoint Therapeutics has entered into an exclusive option and licence agreement with Novartis to develop and commercialise oral covalent inhibitors aimed at treating various inflammatory diseases
Solid Biosciences Receives FDA Fast Track Designation for Gene Therapy Targeting CPVT
Thursday, July 24, 2025Solid Biosciences Inc has received Fast Track designation from the US Food and Drug Administration FDA for its investigational gene therapy SGT CPVT affects approximately in people globally It typically emerges in childhood or adolescence and is of...
Sutro Biopharma Enters into Collaboration with US FDA to Advance Antibody Drug Conjugate Standards
Wednesday, July 23, 2025Sutro Biopharma has announced a new research collaboration with the United States Food and Drug Administration FDA aimed at advancing regulatory standards for antibody drug conjugates ADCs
AusperBio Granted Approval to Begin Phase III Trial of AHB-137 for Chronic Hepatitis B
Tuesday, July 22, 2025AusperBio has received clearance from the China Centre for Drug Evaluation CDE to initiate a Phase III clinical trial of AHB their lead investigational candidate for the treatment of chronic hepatitis B CHB
ProMIS Neurosciences Receives FDA Fast Track Designation for PMN310 in Alzheimer’s Disease
Tuesday, July 22, 2025ProMIS Neurosciences has been granted Fast Track designation by the US Food and Drug Administration FDA for its lead candidate PMN aimed at treating Alzheimers disease AD
Sanofi to Acquire Vicebio to Strengthen Respiratory Vaccines
Tuesday, July 22, 2025Sanofi has announced an agreement to acquire VicebioThis acquisition will add an earlystage vaccine candidate targeting respiratory syncytial virus RSV and human metapneumovirus hMPV to Sanofis portfolio
Aldeyra Therapeutics’ Reproxalap NDA Accepted for Review by US FDA for Dry Eye Disease
Friday, July 18, 2025Aldeyra Therapeutics has announced that the US Food and Drug Administration FDA has accepted the resubmitted New Drug Application NDA for reproxalap a topical ocular treatment developed for dry eye disease
